Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.

Cancers (Basel) · 2022 · PMC8870624 · PMID 35205765

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significancep = 0.054so close (0.05 < p ≤ 0.1)

The favorable prognostic impact on PFS of SOCS1 mutations described in the prior report [ 36 ] was maintained, although with borderline significance, also in the cohort analyzed by the present study (2-year PFS 93% vs. 70%, p = 0.054), while there was no evident impact on OS (100.0% vs. 86.8% at 2 years, p = 0.167).

also in 6,786 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.